IAVI and Moderna partner to tackle broad global health priorities using mRNA for vaccines and antibodies
IAVI | News Release | April 7, 2022
Trial of innovative HIV vaccine using mRNA technology enrolls first participant
HVTN | New Release | March 14, 2022
Translating the Language of Immunity
An advocate for equitable representation in science, doctoral student Nick Maurice was awarded the 2021 Graduate School Medal
UW Graduate School | May 26, 2021
People who have had COVID should get single vaccine dose, studies suggest
New studies show that one shot of a vaccine can greatly amplify antibody levels in those who have recovered from the coronavirus.
New York Times | Feb. 19, 2021
Black volunteers give COVID-19 vaccine trials a shot in the arm
Study participant discusses the importance of diversity in the COVID-19 trials.
Seattle Times | Dec. 14, 2020
Bonney Lake woman in COVID-19 vaccine trial says mild side effects are worth it
Volunteer participating in the AstraZeneca COVID-19 vaccine trials talks about mild symptoms.
KING5 | Dec. 10, 2020
Covid vaccines are coming soon, but must overcome public's safety doubts
Dr. Julie McElrath is interviewed about the Moderna and Pfizer vaccines.
Puget Sound Business Journal | Dec. 1, 2020
Despite hopeful vaccine news, Thanksgiving warnings remain dire
Dave Ross and Aaron Granillo chat with Dr. Julie McElrath about the early results of the Pfizer vaccine trial.
KIRO Radio | Nov. 12, 2020
Russia’s claim of a successful COVID-19 vaccine doesn’t pass the ‘smell test,’ critics say
Dr. Julie McElrath shares her concerns on the AD5 vector.
Science | Nov. 11, 2020
Roll Up Your Sleeve to Fight COVID-19: Three New Vaccine Trials Will Start Soon in the Seattle Area
Dr. Julie McElrath is interviewed about her vaccine study>
The Daily Chronical | Nov. 9, 2020
Seattle vaccine researchers react to Pfizer, still need volunteers
Dr. Julie McElrath talks about the phase 3 Astra Zeneca trials that she is leading.
KIRO 7 | Nov. 9, 2020
Pfizer’s COVID-19 vaccine shows promise, but don’t expect it in pharmacy anytime soon
Drs. Julie McElrath and Anna Wald are interview about AstraZeneca entering phase 3 human trial and the need for volunteers.
Q13 Fox | Nov. 9, 2020
Immunology institute founded by Paul Allen shifts focus to tackle coronavirus
Dr. Julie McElrath discussed the benefits of working with the Allen Institute for COVID-19 research.
The Seattle Times | Aug. 15, 2020
Fred Hutch and Allen Institute launch study of milder COVID-19 cases, aiming for unique insights
Dr. Julie McElrath’s work with the Allen Institute to understand the characteristics of an effective COVID-19 immune response was covered by GeekWire.
GeekWire | Aug. 13, 2020
Everett Firefighters joining Fred Hutch COVID-19 study
Fred Hutch researchers tested firefighters for active COVID-19 to understand first responders exposure
KIRO7 | August 3, 2020
Fred Hutch studies immune response to COVID-19 needs participants
Dr. Julie McElrath is recruiting volunteers who have had coronavirus to look at immune response.
KIRO7 | June 28, 2020